Synthesis 2011(10): 1555-1560  
DOI: 10.1055/s-0030-1260010
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

A Chemo-Enzymatic Synthesis of β-d-Arabinofuranosyl Purine Nucleosides

Irina D. Konstantinovaa, Konstantin V. Antonova, Ilja V. Fateeva, Anatoly I. Miroshnikova, Vladimir A. Stepchenkob, Alexander V. Baranovskyb, Igor A. Mikhailopulo*b
a Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya 16/10, Moscow B-437, 117997 GSP, Russian Federation
b Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, Acad. Kuprevicha 5/2, 220141 Minsk, Belarus
Fax: +375(17)2678761; e-Mail: igor_mikhailo@yahoo.de;
Further Information

Publication History

Received 18 November 2010
Publication Date:
19 April 2011 (online)

Abstract

A chemo-enzymatic synthesis of 9-(β-d-arabinofuranosyl)-2-fluoroadenine (Fludarabine) and 9-(β-d-arabinofuranosyl)-2-amino-6-methoxypurine (Nelarabine) using α-d-arabinofuranose 1-phosphate as a universal substrate and recombinant E. coli purine nucleoside phosphorylase (PNP) as a biocatalyst is described. MacDonald’s method was employed for the synthesis of α-d-arabinofuranose 1-phosphate, which was prepared as a mixture with β-d-arabinopyranose 1-phosphate, starting from peracyl derivatives of d-arabinose of different isomeric (anomeric) composition. It was found that the mixed phosphates can be successfully used in the reaction with purine base catalyzed by PNP pointing to the inertia of β-d-arabinopyranose 1-phosphate in regard to PNP. Reaction of 2-fluoroadenine and α-d-arabinofuranose 1-phosphate is shifted towards the formation of Fludarabine, whereas the reaction of 2-amino-6-methoxypurine reached equilibrium at a ca. equimolar ratio of the base and Nelarabine. Recombinant E. coli uridine phosphorylase catalyzed the synthesis of 1-(β-d-arabinofuranosyl)thymine (ara-T) from thymine and α-d-arabinofuranose 1-phosphate.

    References

  • 1a Mikhailopulo IA. Curr. Org. Chem.  2007,  11:  317 
  • 1b Mikhailopulo IA. Miroshnikov AI. Acta Naturae  2010,  2:  36 
  • 1c Mikhailopulo IA. Miroshnikov AI. Mendeleev Commun.  2011,  21:  57 
  • 2 Lewkowics ES. Iribarren AM. Curr. Org. Chem.  2006,  10:  1197 
  • 3a Ouwerkerk N. van Boom JH. Lugtenburg J. Raap J. Eur. J. Org. Chem.  2000,  861 
  • 3b Ouwerkerk N. Steenweg M. De Ruijter M. Brouwer J. van Boom JH. Lugtenburg J. Raap J. J. Org. Chem.  2002,  67:  1480 
  • 4a Ogawa J. Saito K. Sakai T. Horinouchi N. Kawano T. Matsumoto S. Sasaki M. Mikami Y. Shimizu S. Biosci., Biotechnol., Biochem.  2003,  67:  933 
  • 4b Ishige T. Honda K. Shimizu S. Curr. Opin. Chem. Biol.  2005,  9:  174 
  • 5a Horinouchi N. Ogawa J. Kawano T. Sakai T. Saito K. Matsumoto S. Sasaki M. Mikami Y. Shimizu S. Appl. Microbiol. Biotechnol.  2006,  71:  615 
  • 5b Horinouchi N. Ogawa J. Kawano T. Sakai T. Saito K. Matsumoto S. Sasaki M. Mikami Y. Shimizu S. Biosci., Biotechnol., Biochem.  2006,  70:  1371 
  • 5c Horinouchi N. Ogawa J. Kawano T. Sakai T. Saito K. Matsumoto S. Sasaki M. Mikami Y. Shimizu S. Biotechnol. Lett.  2006,  28:  877 
  • 5d Ogawa J. New Biotechnol.  2009,  26:  75 
  • 6 Taverna-Porro M. Bouvier LA. Pereira CA. Montserrat JM. Iribarren AM. Tetrahedron Lett.  2008,  49:  2642 
  • 7a Komatsu H. Awano H. J. Org. Chem.  2002,  67:  5419 
  • 7b Komatsu H. Ikeda I. Nucleosides, Nucleotides Nucleic Acids  2003,  22:  1685 
  • 8 Komatsu H. Araki T. Tetrahedron Lett.  2003,  44:  2899 
  • 9a Komatsu H. Awano H. Ishibashi H. Oikawa I. Araki T. Nucleic Acids Symp. Ser.  2003,  3:  101 
  • 9b Komatsu H. Araki T. Nucleosides, Nucleotides Nucleic Acids  2005,  24:  1127 
  • 10a Yamada K. Matsumoto N. Hayakawa H. Nucleic Acids Symp. Ser.  2004,  48:  45 
  • 10b Yamada K. Matsumoto N. Hayakawa H. Nucleosides, Nucleotides Nucleic Acids  2009,  28:  1117 
  • 11 de Lederkremer RM. Nahmad VB. Varela O. J. Org. Chem.  1994,  59:  690 
  • 12 Euzen R. Ferrieres V. Plusquellec D. J. Org. Chem.  2005,  70:  847 ; and references cited therein
  • 13 Hanessian S. Lou B. Chem. Rev.  2000,  100:  4443 
  • 14a MacDonald DL. J. Org. Chem.  1962,  27:  1107 
  • 14b MacDonald DL. Carbohydr. Res.  1966,  3:  117 
  • 14c MacDonald DL. Carbohydr. Res.  1968,  6:  376 
  • 14d Mendicino J. Hanna R. J. Biol. Chem.  1970,  245:  6113 
  • 14e Chittenden GJF. Carbohydr. Res.  1972,  25:  35 
  • 15 Wright RS. Khorana HG. J. Am. Chem. Soc.  1958,  80:  1994 ; see also detailed discussion in this paper
  • 16 Maryanoff BE. Reitz AB. Nortey SO. Tetrahedron  1988,  44:  3093 
  • 17 Aspinall GO. Cottrell IW. Matheson NK. Can. J. Biochem.  1972,  50:  574 
  • 18 Kobayashi M. Tetrahedron  2002,  58:  9365 
  • 19 Hanessian S. Lu P.-P. Ishida H. J. Am. Chem. Soc.  1998,  120:  13296 
  • 20 Plesner PE. Klenow H. Methods Enzymol.  1957,  3:  181 
  • 21 Sokolov VM. Rusavskaya TN. Studentsov EP. Zaharov VI. Ivanov MA. Sochilin EG. Zh. Obshch. Khim.  1981,  51:  946 ; Chem. Abstr. 1981, 95, 133270
  • 22 Kam BL. Oppenheimer NJ. Carbohydr. Res.  1979,  69:  308 
  • 23 Bock K. Pedersen C. Carbohydr. Res.  1973,  29:  331 
  • 24 Kam BL. Barascut J.-L. Imbach J.-L. Carbohydr. Res.  1979,  69:  135 
  • 25 Lichtenthaler FW. Breunig J. Fischer W. Tetrahedron Lett.  1971,  12:  2825 
  • 27 Asseline U. Hau J.-F. Czernecki S. Diguarher T. Perlat M.-C. Valery J.-M. Thuong NT. Nucleic Acids Res.  1991,  19:  4067 
  • 28 Esipov RS. Gurevich AI. Chuvikovsky DV. Chupova LA. Muravyova TI. Miroshnikov AI. Protein Expr. Purif.  2002,  24:  56 
  • 29 Averett DR. Koszalka GW. Fyfe JA. Roberts GB. Purifoy DJ. Krenitsky TA. Antimicrob. Agents Chemother.  1991,  35:  851 
  • 30 Roivainen J. Elizarova T. Lapinjoki S. Mikhailopulo IA. Esipov RS. Miroshnikov AI. Nucleosides, Nucleotides Nucleic Acids  2007,  26:  905 
  • 32 Montgomery JA. Hewson K. J. Med. Chem.  1969,  12:  498 
  • 33 Mikhailopulo IA. Kalinichenko E. N. Zaitseva G. V. Akhrem AA. Biol. Mass. Spectrom.  1982,  9:  225 
  • 34 Chattopadhyaya J. Reese C. B. Synthesis  1978,  908 
  • 35 Schinazi RF. Chen M. S. Prusoff WH. J. Med. Chem.  1979,  22:  1273 
26

It is noteworthy that a mixture of the 1α and 1β furanosides¹5 is unstable at r.t. giving rise to the formation of two new fractions that have been isolated by silica gel column chromatography. One of them consists of two triacetates (¹H, ¹³C NMR). Detailed NMR analysis (¹H, ¹³C NMR; COSY, HMBC, TOCSY, and NOE) along with the ab initio geometry optimization (HyperChem, 8.1; in vacuo, basis set; 6-31G*) of the relevant structures led us to conclusion that the major constituent is 2,3,5-tri-O-acetyl-α-d-arabino-furanose and the minor is 2,3,4-tri-O-acetyl-β-d-arabino-pyranose. The formation of the former as a byproduct was previously mentioned²² in the transformation of methyl 2,3,5-tri-O-acetyl-α-d-arabinofuranoside into 1,2,3,5-tetra-O-acetyl-α-d-arabinofuranose through the intermediate
1-bromide, however, no NMR data was given. The other fraction consists of three (ca. 1:1:1 according to ¹H NMR) supposedly acyclic closely related isomeric tetraacetates, the structures of which have not yet been established.

31

Tintagel Ltd, 2nd Floor, Eton Tower, 8 Hysan Avenue, Causeway Bay, Hong Kong; Tel.: +852(2910)7843; Fax: +852(2910)7844; E-mail: kacin@netvigator.com.